These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24886334)

  • 1. The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.
    Parameswaran N; Russell GC; Bartley K; Grant DM; Deane D; Todd H; Dagleish MP; Haig DM
    Vet Res; 2014 May; 45(1):59. PubMed ID: 24886334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
    Russell GC; Benavides J; Grant D; Todd H; Deane D; Percival A; Thomson J; Connelly M; Haig DM
    Vet Res; 2012 Jun; 43(1):51. PubMed ID: 22686373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
    Haig DM; Grant D; Deane D; Campbell I; Thomson J; Jepson C; Buxton D; Russell GC
    Vaccine; 2008 Aug; 26(35):4461-8. PubMed ID: 18601965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen
    Lankester F; Lugelo A; Werling D; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Smith S; Parameswaran N; Cleaveland S; Russell G; Haig D
    Vet Microbiol; 2016 Nov; 195():144-153. PubMed ID: 27771060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.
    Bartley K; Deane D; Percival A; Dry IR; Grant DM; Inglis NF; Mclean K; Manson ED; Imrie LH; Haig DM; Lankester F; Russell GC
    Vet Microbiol; 2014 Sep; 173(1-2):17-26. PubMed ID: 25091530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised vaccine field trial in Kenya demonstrates protection against wildebeest-associated malignant catarrhal fever in cattle.
    Cook E; Russell G; Grant D; Mutisya C; Omoto L; Dobson E; Lankester F; Nene V
    Vaccine; 2019 Sep; 37(40):5946-5953. PubMed ID: 31473000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.
    Ioannou XP; Griebel P; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
    J Virol; 2002 Sep; 76(18):9002-10. PubMed ID: 12186884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.
    Taus NS; O'Toole D; Herndon DR; Cunha CW; Warg JV; Seal BS; Brooking A; Li H
    Vet Microbiol; 2014 Aug; 172(1-2):318-22. PubMed ID: 24803260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small RNA deep sequencing identifies viral microRNAs during malignant catarrhal fever induced by alcelaphine herpesvirus 1.
    Sorel O; Tuddenham L; Myster F; Palmeira L; Kerkhofs P; Pfeffer S; Vanderplasschen A; Dewals BG
    J Gen Virol; 2015 Nov; 96(11):3360-3372. PubMed ID: 26329753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.
    Rankin R; Pontarollo R; Gomis S; Karvonen B; Willson P; Loehr BI; Godson DL; Babiuk LA; Hecker R; van Drunen Littel-van den Hurk S
    Vaccine; 2002 Jul; 20(23-24):3014-22. PubMed ID: 12126915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.
    Myster F; Palmeira L; Sorel O; Bouillenne F; DePauw E; Schwartz-Cornil I; Vanderplasschen A; Dewals BG
    J Virol; 2015 Apr; 89(7):3630-47. PubMed ID: 25589653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
    Lankester F; Russell GC; Lugelo A; Ndabigaye A; Mnyambwa N; Keyyu J; Kazwala R; Grant D; Percival A; Deane D; Haig DM; Cleaveland S
    Vaccine; 2016 Feb; 34(6):831-8. PubMed ID: 26706270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant catarrhal fever-like disease in Barbary red deer (Cervus elaphus barbarus) naturally infected with a virus resembling alcelaphine herpesvirus 2.
    Klieforth R; Maalouf G; Stalis I; Terio K; Janssen D; Schrenzel M
    J Clin Microbiol; 2002 Sep; 40(9):3381-90. PubMed ID: 12202582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant catarrhal fever induced by Alcelaphine herpesvirus 1 is characterized by an expansion of activated CD3+CD8+CD4- T cells expressing a cytotoxic phenotype in both lymphoid and non-lymphoid tissues.
    Dewals BG; Vanderplasschen A
    Vet Res; 2011 Aug; 42(1):95. PubMed ID: 21859474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling clonal CD8 T cell expansion and identification of essential factors in γ-herpesvirus-induced lymphomagenesis.
    Gong M; Myster F; Azouz A; Sanchez Sanchez G; Li S; Charloteaux B; Yang B; Nichols J; Lefevre L; Javaux J; Leemans S; Nivelles O; van Campe W; Roels S; Mostin L; van den Berg T; Davison AJ; Gillet L; Connelley T; Vermijlen D; Goriely S; Vanderplasschen A; Dewals BG
    Proc Natl Acad Sci U S A; 2024 Aug; 121(32):e2404536121. PubMed ID: 39088396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of malignant catarrhal fever virus in captive wildebeest (Connochaetes sp.) in France.
    Ortiz K; Javaux J; Simon M; Petit T; Clavel S; Lamglait B; Blanc B; Brunet A; Myster F; Li H; Dewals BG
    Transbound Emerg Dis; 2018 Dec; 65(6):1697-1704. PubMed ID: 29962104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.
    Ioannou XP; Gomis SM; Karvonen B; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2002 Nov; 21(1-2):127-37. PubMed ID: 12443671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ovine herpesvirus 2-induced malignant catarrhal fever in rabbits.
    Li H; Cunha CW; Gailbreath KL; O'Toole D; White SN; Vanderplasschen A; Dewals B; Knowles DP; Taus NS
    Vet Microbiol; 2011 Jun; 150(3-4):270-7. PubMed ID: 21419581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.
    Nichani AK; Mena A; Kaushik RS; Mutwiri GK; Townsend HG; Hecker R; Krieg AM; Babiuk LA; Griebel PJ
    Oligonucleotides; 2006; 16(1):58-67. PubMed ID: 16584295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
    Oumouna M; Mapletoft JW; Karvonen BC; Babiuk LA; van Drunen Littel-van den Hurk S
    J Virol; 2005 Feb; 79(4):2024-32. PubMed ID: 15681404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.